Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CANCER TREATMENT BY COMBINED USE OF EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2022/102731
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing an effective cancer treatment method. The present invention provides a cancer treatment method that combines a standard treatment with an EP4 antagonist and an immune checkpoint inhibitor (e.g., an anti-PD-1 antibody). The treatment method according to the present invention is useful in cancer treatment.

Inventors:
KONDO MAKI (JP)
Application Number:
PCT/JP2021/041650
Publication Date:
May 19, 2022
Filing Date:
November 12, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ONO PHARMACEUTICAL CO (JP)
International Classes:
A61K31/353; A61K31/282; A61K31/337; A61K31/513; A61K31/519; A61K31/7068; A61K39/395; A61K45/00; A61P1/00; A61P35/00; A61P35/04; A61P37/04; A61P43/00
Domestic Patent References:
WO2018008711A12018-01-11
WO2017014177A12017-01-26
WO2020111018A12020-06-04
WO2019117269A12019-06-20
WO2016111347A12016-07-14
WO2016111347A12016-07-14
WO2018008711A12018-01-11
WO2001062708A12001-08-30
WO2002020462A12002-03-14
WO2002032900A22002-04-25
WO2002050031A12002-06-27
WO2002050032A12002-06-27
WO2002050033A12002-06-27
WO2002016311A12002-02-28
WO2003086390A12003-10-23
WO2003087061A12003-10-23
WO2003099857A12003-12-04
WO2003016254A12003-02-27
WO2005021508A12005-03-10
WO2004067524A12004-08-12
WO2005037812A12005-04-28
WO2005061475A22005-07-07
WO2005105732A12005-11-10
WO2005105733A12005-11-10
WO2006122403A12006-11-23
WO2007121578A12007-11-01
WO2008017164A12008-02-14
WO2008104055A12008-09-04
WO2008116304A12008-10-02
WO2008123207A12008-10-16
WO2007143825A12007-12-21
WO2009005076A12009-01-08
WO2009139373A12009-11-19
WO2010019796A12010-02-18
WO2010034110A12010-04-01
WO2012039972A12012-03-29
WO2012043634A12012-04-05
WO2012076063A12012-06-14
WO2012103071A22012-08-02
WO2013004290A12013-01-10
WO2013096496A22013-06-27
WO2013096501A12013-06-27
WO2013101733A12013-07-04
WO2013101598A12013-07-04
WO2014004229A12014-01-03
WO2014004230A12014-01-03
WO2014086739A12014-06-12
WO2014126746A12014-08-21
WO2014186218A12014-11-20
WO2014200075A12014-12-18
WO2015094902A12015-06-25
WO2015094912A12015-06-25
WO2015091475A12015-06-25
WO2015113057A12015-07-30
WO2015147020A12015-10-01
WO2016021742A12016-02-11
WO2016088903A12016-06-09
WO2017014323A12017-01-26
WO2017066633A12017-04-20
WO2017085198A12017-05-26
WO2018195123A12018-10-25
WO2018210987A12018-11-22
WO2018210988A12018-11-22
WO2018210992A12018-11-22
WO2018210994A12018-11-22
WO2018210995A12018-11-22
WO2018216640A12018-11-29
WO2019038156A12019-02-28
WO2019245590A12019-12-26
WO2019101171A12019-05-31
WO2019152982A12019-08-08
WO2019166022A12019-09-06
WO2020012305A12020-01-16
WO2020014465A12020-01-16
WO2020151566A12020-07-30
WO2020160075A12020-08-06
WO2020161275A12020-08-13
WO2006007448A22006-01-19
WO2006121168A12006-11-16
WO2008156712A12008-12-24
WO2007005874A22007-01-11
WO2001014424A22001-03-01
Foreign References:
JP2018021013A2018-02-08
CN108929281A2018-12-04
Other References:
CHAN KELVIN, SHAH KEYA, LIEN KELLY, COYLE DOUG, LAM HENRY, KO YOO-JOUNG: "A Bayesian Meta-Analysis of Multiple Treatment Comparisons of Systemic Regimens for Advanced Pancreatic Cancer", PLOS ONE, vol. 9, no. 10, 6 October 2014 (2014-10-06), pages e108749, XP055929395, DOI: 10.1371/journal.pone.0108749
EDWARD B GARON, TUDOR-ELIADE CIULEANU, OSCAR ARRIETA, KUMAR PRABHASH, KONSTANTINOS N SYRIGOS, TUNCAY GOKSEL, KEUNCHIL PARK, VERA G: "Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial", THE LANCET, ¬J.B. FLINT|, vol. 384, no. 9944, 1 August 2014 (2014-08-01), pages 665 - 673, XP055184786, ISSN: 01406736, DOI: 10.1016/S0140-6736(14)60845-X
YOH, TOMOAKI: "A Case of Effective Neoadjuvant Chemoradiotherapy with Capecitabine for Locally Advanced Sigmoid Colon Cancer", JAPANESE JOURNAL OF CANCER AND CHEMOTHERAPY, vol. 38, no. 6, 1 January 2011 (2011-01-01), JP , pages 1021 - 1024, XP009536660, ISSN: 0385-0684
JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, vol. 12, 1995, pages 379 - 391
PHARMACOLOGICAL REVIEWS, vol. 65, July 2013 (2013-07-01), pages 1010 - 1052
"105th Annual Meeting of American Association for Cancer Research (AACR), Abstract: LB-265", TITLE OF PRESENTATION: ONO-AE3-208 INHIBITS MYELOID DERIVED SUPPRESSOR CELLS AND GLIOMA GROWTH, DATE OF PRESENTATION, 8 April 2014 (2014-04-08)
FEBS LETTERS, vol. 364, 1995, pages 339 - 341
CANCER SCIENCE, vol. 105, 2014, pages 1142 - 1151
CANCER RESEARCH, vol. 70, 2010, pages 1606 - 1615
CANCER RESEARCH, vol. 62, 2002, pages 28 - 32
"Molecular Design", vol. 7, 1990, HIROKAWA PUBLISHING COMPANY, article "Development of Drugs", pages: 163 - 198
NATURE REVIEWS CANCER, vol. 12, 2012, pages 252 - 264
CANCER CELL, vol. 27, 2015, pages 450 - 461
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: LIPID-PARTICLE-CONTAINING COSMETIC COMPOSITION INCLUDING PHOSPHOLIPID, AND COSMETIC QUASI-DRUG

Next Patent: COATING AGENT, RESINOUS MEMBER, AND PRODUCTION METHOD THEREFOR